Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV).
Mandorfer M, Aigner E, Cejna M, Ferlitsch A, Datz C, Gräter T, Graziadei I, Gschwantler M, Hametner-Schreil S, Hofer H, Jachs M, Loizides A, Maieron A, Peck-Radosavljevic M, Rainer F, Scheiner B, Semmler G, Reider L, Reiter S, Schoder M, Schöfl R, Schwabl P, Stadlbauer V, Stauber R, Tatscher E, Trauner M, Ziachehabi A, Zoller H, Fickert P, Reiberger T. Mandorfer M, et al. Among authors: datz c. Wien Klin Wochenschr. 2023 Sep;135(Suppl 3):493-523. doi: 10.1007/s00508-023-02229-w. Epub 2023 Jun 26. Wien Klin Wochenschr. 2023. PMID: 37358642 Free PMC article.
Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
Ferenci P, Stauber R, Propst A, Fiedler R, Müller C, Gschwantler M, Schütze K, Datz C, Judmaier G, Vogel W, Krejs GJ, Gangl A. Ferenci P, et al. Among authors: datz c. Dig Dis Sci. 1996 Dec;41(12 Suppl):103S-108S. doi: 10.1007/BF02087884. Dig Dis Sci. 1996. PMID: 9011466 Clinical Trial.
Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon-alpha in interferon nonresponders with chronic hepatitis C.
Ferenci P, Stauber R, Steindl-Munda P, Gschwantler M, Fickert P, Datz C, Müller C, Hackl F, Rainer W, Watkins-Riedel T, Lin W. Ferenci P, et al. Among authors: datz c. J Viral Hepat. 1999 Jul;6 Suppl 1:53-8. doi: 10.1046/j.1365-2893.1999.00005.x. J Viral Hepat. 1999. PMID: 10760037 Clinical Trial.
Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial. Austrian Hepatitis Study Group.
Ferenci P, Stauber R, Steindl-Munda P, Gschwantler M, Fickert P, Datz C, Müller C, Hackl F, Rainer W, Watkins-Riedel T, Lin W, Krejs GJ, Gangl A; Austrian Hepatitis Study Group. Ferenci P, et al. Among authors: datz c. Eur J Gastroenterol Hepatol. 2001 Jun;13(6):699-705. doi: 10.1097/00042737-200106000-00014. Eur J Gastroenterol Hepatol. 2001. PMID: 11434597 Clinical Trial.
Combination of interferon induction therapy and ribavirin in chronic hepatitis C.
Ferenci P, Brunner H, Nachbaur K, Datz C, Gschwantler M, Hofer H, Stauber R, Hackl F, Jessner W, Rosenbeiger M, Munda-Steindl P, Hegenbarth K, Gangl A, Vogel W; Australian Hepatitis Study Group. Ferenci P, et al. Among authors: datz c. Hepatology. 2001 Nov;34(5):1006-11. doi: 10.1053/jhep.2001.28706. Hepatology. 2001. PMID: 11679972 Clinical Trial.
Mutations of the HFE gene in patients with hepatocellular carcinoma.
Cauza E, Peck-Radosavljevic M, Ulrich-Pur H, Datz C, Gschwantler M, Schöniger-Hekele M, Hackl F, Polli C, Rasoul-Rockenschaub S, Müller C, Wrba F, Gangl A, Ferenci P. Cauza E, et al. Among authors: datz c. Am J Gastroenterol. 2003 Feb;98(2):442-7. doi: 10.1111/j.1572-0241.2003.07222.x. Am J Gastroenterol. 2003. PMID: 12591066
Impact of high-dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapy.
Steindl-Munda P, Ferenci P, Brunner H, Nachbaur K, Datz C, Gschwantler M, Hofer H, Stauber R, Hackl F, Jessner W, Rosenbeiger M, Gangl A, Vogel W; Austrian Hepatitis Study Group. Steindl-Munda P, et al. Among authors: datz c. Liver Int. 2003 Aug;23(4):269-75. doi: 10.1034/j.1600-0676.2003.00838.x. Liver Int. 2003. PMID: 12895267 Clinical Trial.
192 results